GGrantIndex
Sort

8,912 grants matching sars cov 2

Cognitive strategy training in Post-COVID-19 Syndrome: A feasibility trial.

$430,375
Anna Boone · University Of Missouri-Columbia · R21 · FY2023 · HD

Manipulating nucleic acids: applications in RNA biosensing, single-molecule analysis, and DNA nanotechnology

$430,375
Ken A Halvorsen · State University Of New York At Albany · R35 · FY2024 · GM

Manipulating nucleic acids: applications in RNA biosensing, single-molecule analysis, and DNA nanotechnology

$430,375
Ken A Halvorsen · State University Of New York At Albany · R35 · FY2025 · GM

In vivo tracking of inhaled ACE2 targeting theranostic nanodrugs delivery to the lungs using magnetic particle imaging

$430,375
Ping Wang · Michigan State University · R21 · FY2021 · AI

Modeling viral entry and its inhibition using SARS-CoV

$430,078
Graham Simmons · Vitalant · R01 · FY2010 · AI

Targeting SARS-Related Coronaviruses with a D-peptide Entry Inhibitor

$429,481
Michael S Kay · University Of Utah · R21 · FY2020 · AI

Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug

$429,426
Weidong Wang · National Institute On Aging · ZIA · FY2023 · AG

Group testing for infectious disease detection

$429,353
Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2023 · AI

Group testing for infectious disease detection

$429,353
Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2025 · AI

Group testing for infectious disease detection

$429,353
Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2024 · AI

Administrative Core

$429,218
Amal O Amer · Ohio State University · P01 · FY2025 · AI

Cell Derivation and Maintenance Core

$429,217
Estelle A Cormet-Boyaka · Ohio State University · P01 · FY2025 · AI

Biological Reagents and Infection Core

$429,217
Jianrong Li · Ohio State University · P01 · FY2025 · AI

Role of CASP-11 in SARS-CoV-2-induced lung pathologies and long-term immune protection

$429,216
Prosper N Boyaka · Ohio State University · P01 · FY2025 · AI

Caspr/11-dependent immunothrombosis and neuroinflammation during SARS-CoV-2 infection

$429,216
Amal O Amer · Ohio State University · P01 · FY2025 · AI

CASP-11-dependent RNA modifications and their Role in Multi-Organ Pathologies

$429,216
Jianrong Li · Ohio State University · P01 · FY2025 · AI

High-Throughput Molecular Profiling Core

$429,139
Michael G Katze · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI

COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings

$429,037
Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2023 · AI

Toward a protective Covid-19 vaccine utilizing an established vector platform

$429,000
Matthias Johannes Schnell · Thomas Jefferson University · R21 · FY2020 · AI

Synergistic Interactions of SARs-CoV2 and environmental toxicants in Experimental Parkinsonism

$429,000
Richard J Smeyne · Thomas Jefferson University · R21 · FY2021 · NS

Inflammatory cytokines and pyroptosis in Coronavirus infection

$429,000
Fabio C Re · Rosalind Franklin Univ Of Medicine & Sci · R21 · FY2020 · AI

Chemical composition-viability relationship of bioaerosols through spatial distribution and size-controlled measurements

$429,000
Hui Ouyang · University Of Texas Dallas · R21 · FY2025 · AI

Systems Immunogenetics of Emerging Coronavirus Infections in the Collaborative Cross

$428,666
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI

Systems Immunogenetics of Emerging Coronavirus Infections in the Collaborative Cross

$428,666
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI

The cellular mechanisms of immunological memory development in COVID-19 patients

$428,542
Weiguo Cui · Versiti Wisconsin, Inc. · R56 · FY2021 · AI